Lantheus Holdings (LNTH) EBITDA (2014 - 2026)
Lantheus Holdings (LNTH) reported EBITDA of $81.3 million for Q1 2026, down 20.32% year-over-year from $102.1 million in Q1 2025, and up 5.37% quarter-over-quarter from $77.2 million in Q4 2025.
Lantheus Holdings (LNTH) EBITDA (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of EBITDA data on file, last reported at $81.3 million in Q1 2026.
- EBITDA for Q1 2026 came in at $81.3 million, down 20.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $290.1 million (up 237.56% YoY), and the FY2025 annual result was $310.8 million, up 243.44% from the prior year.
- EBITDA grew to $81.3 million in Q1 2026 per LNTH's latest filing, from $77.2 million in the prior quarter.
- Over five years, EBITDA peaked at $133.7 million in Q3 2024 and troughed at -$252.6 million in Q4 2024.
- A 5-year average of $35.6 million and a median of $81.3 million in 2026 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2024: EBITDA sank 385.81% in 2022, then surged 1241.21% in 2024.
- A 5-year view of EBITDA shows it stood at -$171.7 million in 2022, then climbed by 17.95% to -$140.9 million in 2023, then tumbled by 79.33% to -$252.6 million in 2024, then soared by 130.56% to $77.2 million in 2025, then rose by 5.37% to $81.3 million in 2026.
- Business Quant data shows LNTH's EBITDA at $81.3 million in Q1 2026, $77.2 million in Q4 2025, and $43.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 61.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.33 Mn |
| Dec 31, 2025 | 77.18 Mn |
| Sep 30, 2025 | 43.62 Mn |
| Jun 30, 2025 | 87.97 Mn |
| Mar 31, 2025 | 102.07 Mn |
| Dec 31, 2024 | -252.60 Mn |
| Sep 30, 2024 | 133.74 Mn |
| Jun 30, 2024 | 102.73 Mn |
| Mar 31, 2024 | 106.64 Mn |
| Dec 31, 2023 | -140.86 Mn |
| Sep 30, 2023 | 112.36 Mn |
| Jun 30, 2023 | 124.14 Mn |
| Mar 31, 2023 | -9.34 Mn |
| Dec 31, 2022 | -171.68 Mn |
| Sep 30, 2022 | 85.74 Mn |
| Jun 30, 2022 | 63.20 Mn |
| Mar 31, 2022 | 58.93 Mn |
| Dec 31, 2021 | -35.34 Mn |
| Sep 30, 2021 | -14.33 Mn |
| Jun 30, 2021 | -26.78 Mn |